ReviewFrontiers in pediatrics2026
MSCs and MSC-Exos in pediatric ARDS treatment: translational research and the reshaping of nursing roles.
Review in Frontiers in pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pediatric Acute Respiratory Distress Syndrome (ARDS) is a severe lung condition with high mortality and limited conventional treatments. Mesenchymal stem cells (MSCs), which are special cells that can develop into a variety of cell types, and their tiny vesicles called exosomes (MSC-Exos), are highly promising cell-based therapies for pediatric ARDS because of their anti-inflammatory, immunomodulatory, and tissue-repair functions. This review summarizes current knowledge on MSCs and MSC-Exos in ARDS, including recent progress in studies before human trials and in actual patient trials. It focuses on challenges, needed competency changes, and how nursing roles are evolving in this new therapeutic field. The discussion provides a theoretical foundation for developing a nursing framework to support and enhance patient care with advanced cell therapies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.